Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
LEVOFLOXACIN HJ
GENERIC
Inhibits bacterial DNA replication by inhibiting DNA Gyrase and Toposiomerase IV enzymes
Available at :
Share this article
Related
Articles
Optimizing Diabetes Management During Ramadan: Implementation of the 2025 DaR-ADA-IDF Guidelines
by dr. Alfredo Bambang, MBA | 11 Mar 2026
Secretome Improves Insulin Resistance in Type 2 Diabetes Mellitus
by dr. Esther Kristiningrum | 20 Feb 2026
Metformin and Insulin Aspart in Patients with Gestational Diabetes Mellitus
by dr. Hastarita Lawrenti | 04 Feb 2026
Maturity-onset Diabetes of the Young (MODY), Diabetes that Occurs at a Young Age and is Caused by Mutation in Gene
by dr. Dita Arccinirmala | 01 Dec 2025
World Antimicrobial Resistance Awareness Week - Act Now: Protect Our Present, Secure Our Future
by dr. Dita Arccinirmala | 24 Nov 2025
Insulin Glulisine in Pregnancy: Insights from Clinical Trial and Post Marketing Surveillance
by dr. Verawati Nur | 29 Sep 2025
The Effect of Vitamin D Supplementation on Insulin Sensitivity and Secretion in Prediabetes
by dr. Karen Denisa | 01 Aug 2025
.
by dr. Hastarita Lawrenti | 12 Mar 2025
Strategies for Managing Type 2 Diabetes with FRC Iglarlixi During Ramadan Fasting
by dr. Risya Malida | 18 Feb 2025
Carbohydrate Maltodextrin May Prevent Post-surgical Insulin Resistance
by dr. Dedyanto Henky Saputra, M.Gizi | 15 Jan 2025
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE